425: Gentherm Reports Q1 2026 Results, Announces Modine Combination

Gentherm Incorporated announced its first quarter 2026 financial results, reporting revenue growth and improved gross margin, alongside the strategic combination with Modine Performance Technologies.

Summary

• Gentherm reported first quarter 2026 product revenues of $393.7 million, an increase of 11.3% from $353.9 million in the prior year. Excluding foreign currency impacts, revenue grew 7.2%.
• Gross margin improved to 24.7% from 24.4% in the prior year, driven by operational initiatives and improved volume.
• Net income was $4.2 million, or $0.14 per diluted share, compared to a net loss of $0.1 million, or $(0.00) per diluted share, in the prior year.
• Adjusted EBITDA increased to $49.3 million (12.5% of revenue) from $39.3 million (11.1% of revenue) in the prior year.
• The company announced a transformational combination with Modine Performance Technologies, which is on track to close by the end of 2026.
• First quarter automotive new business awards totaled $395 million.
• The company submitted a 510(k) premarket notification to the FDA for its ThermAffyx Patient Safety System, with expected revenue in Q3 2026.
• Full year 2026 guidance remains unchanged: Product Revenues $1.5B - $1.6B, Adjusted EBITDA $175M - $195M, Adjusted Free Cash Flow $80M - $100M.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth, improved profitability metrics, and a significant strategic transaction announced. While operational cash flow remains a concern, the overall financial performance and strategic direction are encouraging.

Positives

• Product revenues increased by 11.3% year-over-year to $393.7 million, with a 7.2% increase excluding foreign currency impacts.
• Automotive Climate and Comfort Solutions revenue grew 13.6% year-over-year (9.8% ex-FX), outperforming the relevant light vehicle production market by 14 percentage points.
• Gross margin improved to 24.7% from 24.4% due to operational leverage and material performance.
• Net income turned positive at $4.2 million, compared to a net loss of $0.1 million in the prior year.
• Adjusted EBITDA increased by 25.4% to $49.3 million, with a margin expansion to 12.5% from 11.1%.
• Adjusted diluted earnings per share rose to $0.84 from $0.51 in the prior year.
• Cash flow from operations improved to $(5.0) million from $(13.3) million.
• Net leverage decreased to approximately 0.2x.
• Liquidity stood at $455.5 million.
• Secured $395 million in Automotive New Business Awards during the quarter.
• Delivered first home and office solutions to KUKA Home in Asia.
• Submitted 510(k) for ThermAffyx Patient Safety System, targeting Q3 2026 revenue.

Negatives

• Cash flow from operations was negative at $(5.0) million.
• Adjusted Free Cash Flow was negative at $(2.6) million.
• Medical segment revenue decreased by 3.7% year-over-year.
• Other Automotive revenue decreased by 8.1%.

Risks

• The combination with Modine Performance Technologies is subject to closing conditions, including regulatory approvals, and may not be completed on the expected terms or timeline, or at all.
• There is uncertainty regarding the expected financial performance of the combined company post-transaction.
• Failure to realize anticipated benefits of the combination, including revenue and cost synergies, due to integration challenges or delays.
• Potential for unexpected costs, charges, or expenses resulting from the transaction.
• Inability of the combined company to retain and hire key personnel.
• Risk of shareholder litigation or other legal proceedings related to the proposed transaction.
• Evolving legal, regulatory, and tax regimes could impact the transaction or the combined company.
• Changes in general economic and industry-specific conditions, including volatility from tariffs and trade policies.
• The anticipated tax treatment of the transaction may not be obtained.
• Difficulty in separating Modine's Performance Technologies business from its other operations.
• Disruption of management time from ongoing business operations due to the pendency of the transaction.
• Risks related to the automotive industry's evolution towards electric and autonomous vehicles.
• Supply chain constraints and inflationary cost pressures.
• Production level fluctuations from major customers (OEMs).
• Operational, competitive, geopolitical, regulatory, and economic risks specific to the business in China.
• Risks associated with global operations, including cost structure, manufacturing footprint, operations in Ukraine, and foreign currency exchange.
• Product quality and safety issues, including potential recalls or alleged defects.
• Attracting and retaining skilled employees and managing wage inflation.
• Tightening labor markets, labor shortages, or work stoppages impacting the company, customers, or suppliers.
• Achieving product cost reductions to offset customer-imposed price reductions.
• Executing efforts to optimize the global supply chain and manufacturing footprint.
• Risks associated with integrating acquisitions and achieving planned benefits.
• Security breaches and disruptions to IT networks and systems, including data security and privacy risks.
• Loss or insolvency of key customers or suppliers.
• Accuracy of sales volume projections based on third-party information.
• Protection of intellectual property in certain jurisdictions.
• Compliance with global anti-corruption laws and regulations.
• Legal and regulatory proceedings and claims.
• Extensive regulation of the patient temperature management business.
• Risks associated with manufacturing processes.
• Effects of climate change and related regulatory and stakeholder requirements.
• Availability of borrowing under the revolving credit facility and access to capital markets.
• Indebtedness and compliance with debt covenants.

Future Outlook

The company's guidance for full year 2026 remains unchanged, projecting Product Revenues between $1.5 billion and $1.6 billion, Adjusted EBITDA between $175 million and $195 million, and Adjusted Free Cash Flow between $80 million and $100 million. This guidance is based on current tariffs, customer order forecasts, an expected low single-digit decrease in light vehicle production, and a EUR to USD exchange rate of $1.16.

Management Comments

• "Our team executed well in the first quarter. We started seeing the tangible results from our efforts to establish a more robust operating system which drove improved performance on stronger volumes. We also continued progressing our organic growth initiatives in both home and office, and medical markets."
• "This quarter also marked a strategic inflection point for Gentherm. Our announced combination with Modine Performance Technologies creates a stronger enterprise, with an expanded product portfolio, broader end market exposure, and clear value creation opportunities."
• "While we navigate any potential near-team volatility, we are strategically repositioning the company, and I remain confident we have the right plan established to drive improved performance over the long-term."

Industry Context

StockSavvy.ai notes that Gentherm's Q1 2026 results reflect a company navigating industry shifts, particularly in automotive, while pursuing strategic growth through organic initiatives and a significant merger. The reported revenue growth, especially in automotive climate solutions, suggests resilience and market share gains amidst evolving vehicle technologies. The combination with Modine Performance Technologies positions Gentherm to capitalize on broader thermal and precision flow management opportunities across multiple end markets.

Comparison to Industry Standards

• Gentherm's Automotive Climate and Comfort Solutions revenue growth of 9.8% (excluding FX) outperformed S&P Global's mid-April light vehicle production report in their relevant markets by 14 percentage points, indicating strong performance relative to the broader automotive sector.
• The Adjusted EBITDA margin of 12.5% for Q1 2026 is a positive indicator of operational efficiency, though direct comparisons to industry-wide benchmarks for this specific non-GAAP metric require detailed analysis of peer reporting practices.

Legal Proceedings

• The filing mentions the possibility of shareholder litigation in connection with the Proposed Transaction.

Stakeholder Impact

• Shareholders: The proposed combination with Modine Performance Technologies is expected to create a stronger enterprise with clear value creation opportunities, potentially benefiting shareholders through future growth and synergies. However, the transaction is subject to shareholder approval and regulatory conditions.
• Employees: The integration of Gentherm and Modine Performance Technologies may lead to changes in organizational structure and roles. The company also notes the risk of inability to retain and hire key personnel.
• Customers: The expanded product portfolio and broader end-market exposure from the combination could lead to enhanced offerings and solutions for customers. The company also notes risks related to customer production levels and potential loss or insolvency of key customers.
• Suppliers: Supply chain constraints and inflationary cost pressures are mentioned as risks, which could impact supplier relationships and costs.
• Creditors: The company's net leverage is low (~0.2x), and liquidity is strong ($455.5 million), suggesting a stable position for creditors. The combination may impact future debt levels and covenants.

Next Steps

• Host conference call to discuss Q1 2026 results.
• Continue progressing organic growth initiatives in home and office, and medical markets.
• Work towards closing the combination with Modine Performance Technologies by the end of 2026.
• Prepare for expected revenue generation from the ThermAffyx Patient Safety System in Q3 2026.
• File relevant materials with the SEC, including Form S-4 and Form 10, in connection with the proposed transaction.

Key Dates

Recommendation

The company is showing improved operational performance and has announced a significant strategic combination. However, the full benefits and risks of the Modine transaction are yet to be realized, and the integration process carries inherent uncertainties. The unchanged full-year guidance suggests a steady outlook. Therefore, a 'hold' recommendation is appropriate pending further clarity on the transaction's execution and its impact on future financial results.

Keywords

Gentherm, Form 8-K, Q1 2026 Results, Modine Manufacturing Company, Modine Performance Technologies, Merger, Acquisition, Thermal Management, Pneumatic Comfort, Automotive, Medical, Financial Results, Revenue, Gross Margin, EBITDA, Earnings Per Share, SEC Filing